Related references
Note: Only part of the references are listed.Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?
Iakov N Rudenko et al.
BMC Medicine (2012)
(G2019S) LRRK2 activates MKK4-JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PD
C-Y Chen et al.
CELL DEATH AND DIFFERENTIATION (2012)
Neurocognitive dysfunction in the highly active antiretroviral therapy era
Nomvuyo Z. Mothobi et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2012)
Parkinson's disease and immune system: is the culprit LRRKing in the periphery?
Elisa Greggio et al.
JOURNAL OF NEUROINFLAMMATION (2012)
LRRK2 Inhibition Attenuates Microglial Inflammatory Responses
Mark S. Moehle et al.
JOURNAL OF NEUROSCIENCE (2012)
Disrupted Autophagy Leads to Dopaminergic Axon and Dendrite Degeneration and Promotes Presynaptic Accumulation of α-Synuclein and LRRK2 in the Brain
Lauren G. Friedman et al.
JOURNAL OF NEUROSCIENCE (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
PARKINSON'S DISEASE-LINKED LEUCINE-RICH REPEAT KINASE 2(R1441G) MUTATION INCREASES PROINFLAMMATORY CYTOKINE RELEASE FROM ACTIVATED PRIMARY MICROGLIAL CELLS AND RESULTANT NEUROTOXICITY
F. Gillardon et al.
NEUROSCIENCE (2012)
LRRK2 Phosphorylates Tubulin-Associated Tau but Not the Free Molecule: LRRK2-Mediated Regulation of the Tau-Tubulin Association and Neurite Outgrowth
Fumitaka Kawakami et al.
PLOS ONE (2012)
Impaired Inflammatory Responses in Murine Lrrk2-Knockdown Brain Microglia
Beomsue Kim et al.
PLOS ONE (2012)
The IkappaB Kinase Family Phosphorylates the Parkinson's Disease Kinase LRRK2 at Ser935 and Ser910 during Toll-Like Receptor Signaling
Nicolas Dzamko et al.
PLOS ONE (2012)
Eaten alive! Cell death by primary phagocytosis: 'phagoptosis'
Guy C. Brown et al.
TRENDS IN BIOCHEMICAL SCIENCES (2012)
Primary phagocytosis of neurons by inflamed microglia: potential roles in neurodegeneration
Jonas J. Neher et al.
FRONTIERS IN PHARMACOLOGY (2012)
Rac1 Protein Rescues Neurite Retraction Caused by G2019S Leucine-rich Repeat Kinase 2 (LRRK2)
Diane Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Neuronal Death Induced by Nanomolar Amyloid β Is Mediated by Primary Phagocytosis of Neurons by Microglia
Urte Neniskyte et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Inhibition of Microglial Phagocytosis Is Sufficient To Prevent Inflammatory Neuronal Death
Jonas J. Neher et al.
JOURNAL OF IMMUNOLOGY (2011)
Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures
Mansoureh Hakimi et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Genetic and functional heterogeneity of CNS-derived tat alleles from patients with HIV-associated dementia
Daniel Cowley et al.
JOURNAL OF NEUROVIROLOGY (2011)
A QUICK Screen for Lrrk2 Interaction Partners - Leucine-rich Repeat Kinase 2 is Involved in Actin Cytoskeleton Dynamics
Andrea Meixner et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
Xianming Deng et al.
NATURE CHEMICAL BIOLOGY (2011)
The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease
Zhihua Liu et al.
NATURE IMMUNOLOGY (2011)
Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice
B. Winner et al.
NEUROBIOLOGY OF DISEASE (2011)
Dopaminergic Neuronal Loss, Reduced Neurite Complexity and Autophagic Abnormalities in Transgenic Mice Expressing G2019S Mutant LRRK2
David Ramonet et al.
PLOS ONE (2011)
HIV-1 Tat-Induced Microgliosis and Synaptic Damage via Interactions between Peripheral and Central Myeloid Cells
Shao-Ming Lu et al.
PLOS ONE (2011)
Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization
Nicolas Dzamko et al.
BIOCHEMICAL JOURNAL (2010)
Biochemical and molecular features of LRRK2 and its pathophysiological roles in Parkinson's disease
Wongi Seol
BMB REPORTS (2010)
LRRK2 Is Involved in the IFN-γ Response and Host Response to Pathogens
Agnes Gardet et al.
JOURNAL OF IMMUNOLOGY (2010)
Phosphopeptide Analysis Reveals Two Discrete Clusters of Phosphorylation in the N-Terminus and the Roc Domain of the Parkinson-Disease Associated Protein Kinase LRRK2
Christian Johannes Gloeckner et al.
JOURNAL OF PROTEOME RESEARCH (2010)
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy CHARTER Study
R. K. Heaton et al.
NEUROLOGY (2010)
Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of α-synuclein, and apoptotic cell death in aged mice
Youren Tong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Leucine-Rich Repeat Kinase 2 (LRRK2): A Key Player in the Pathogenesis of Parkinson's Disease
Payal N. Gandhi et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
In vivo expression of proinflammatory cytokines in HIV encephalitis: an analysis of 11 autopsy cases
Hui Qin Xing et al.
NEUROPATHOLOGY (2009)
Role of Tat Protein in HIV Neuropathogenesis
Wenxue Li et al.
NEUROTOXICITY RESEARCH (2009)
Genomewide Association Study of Leprosy
Fu-Ren Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells
Edward D. Plowey et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Human Immunodeficiency Virus Protein Tat Induces Synapse Loss via a Reversible Process That Is Distinct from Cell Death
Hee Jung Kim et al.
JOURNAL OF NEUROSCIENCE (2008)
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
Jeffrey C. Barrett et al.
NATURE GENETICS (2008)
BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module
Daeho Park et al.
NATURE (2007)
Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-α-mediated neurotoxicity
Lara Buscemi et al.
NEUROBIOLOGY OF DISEASE (2007)
The familial parkinsonism gene LRRK2 regulates neurite process morphology
David MacLeod et al.
NEURON (2006)
Apoptotic cells induce a phosphatidyiserine-dependent homeostatic response from phagocytes
Robert S. Kiss et al.
CURRENT BIOLOGY (2006)
Localization of LRRK2 to membranous and vesicular structures in mammalian brain
Saskia Biskup et al.
ANNALS OF NEUROLOGY (2006)
Inhibition of mixed lineage kinase 3 prevents HIV-1 Tat-mediated neurotoxicity and monocyte activation
Ziye Sui et al.
JOURNAL OF IMMUNOLOGY (2006)
Phosphatidylserine recognition by phagocytes: a view to a kill
Y Wu et al.
TRENDS IN CELL BIOLOGY (2006)
CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: A potential mechanism of HIV-CNS invasion and NeuroAIDS
EA Eugenin et al.
JOURNAL OF NEUROSCIENCE (2006)
HIV-1 tat and opiate-induced promote chemotaxis of microglia changes in astrocytes through the expression of MCP-1 and alternative chemokines
N El-Hage et al.
GLIA (2006)
Microfluidic culture platform for neuroscience research
Jeong Won Park et al.
NATURE PROTOCOLS (2006)
Immunocytochemistry and quantification of protein colocalization in cultured neurons
Marian W. Glynn et al.
NATURE PROTOCOLS (2006)
Anatomical localization of Leucine-rich repeat kinase 2 in mouse brain
H Melrose et al.
NEUROSCIENCE (2006)
Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images
E Meijering et al.
CYTOMETRY PART A (2004)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
HIV-1-associated dementia: A metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes
E Anderson et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2002)